To access this element change to forms mode OFF
Grant Award View - GA217904
A Platform trial of combination precision guided therapies for high risk...
GA ID:
GA217904
Agency:
Department of Health and Aged Care
Approval Date:
6-Dec-2021
Publish Date:
16-Feb-2022
Category:
Health and Medical Research
Grant Term:
1-Feb-2022 to 31-Jan-2027
Value (AUD):
$1,515,180.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
MRFF Research Grants
Grant Activity:
A Platform trial of combination precision guided therapies for high risk childhood cancer
Purpose:
Zero Childhood Cancer is a world leading program that uses genomic sequencing to identify new treatment strategies for children with the most aggressive cancers. Here we will develop a companion clinical trial which will test new combinations of targeted drugs, to treat high risk childhood cancers based on each child’s individual tumour profile.
GO ID:
GO Title:
MRFF 2021 Rare Cancers Rare Diseases Unmet Need General - Grant Opportunity
Internal Reference ID:
2021/MRF2014748
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Sydney
Town/City:
Sydney
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC, SA, WA, QLD, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, CANADA, GERMANY